Thyrocare Q2 Profit Slips 68% YoY To ₹15 Cr Due To ₹45 Cr Exceptional Expense
The profit slump was driven by an exceptional loss on investment in Nueclear Healthcare Limited, which Thyrocare is selling to Trovera Healthcare for ₹141.4 Cr. Despite the profit dip, operating revenue grew 25% year-on-year to ₹270.8 Cr, with strong growth in diagnostic testing services.
Key points
- Net profit dropped to ₹15.2 Cr from ₹47.8 Cr YoY
- Exceptional impairment loss of ₹45 Cr on Nueclear Healthcare Limited
- Operating revenue increased 25% to ₹270.8 Cr
- Divestment of imaging business to focus on pathology
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Inc42 did the reporting; read the original for the full story.
Read the full story at Inc42
